4
Changes in Ownership
Axsome Therapeutics, Inc. Filed Acc 0000950170-24-094967
Chief Operating Officer sold 47,739 shares at $84.26 ($4,022,488)
- Chief Operating Officer acquired 47,739 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Jacobson Mark L. Chief Operating Officer | 2024-08-09 | Option exercise 10b5-1 | +47,739 | $4.04 | $192,866 | 53,522 | D |
| Jacobson Mark L. Chief Operating Officer | 2024-08-09 | Sale 10b5-1 | −47,739 | $84.26 | $4,022,488 | 5,783 | D |
| Derivatives | |||||||
| Jacobson Mark L. Chief Operating Officer | 2024-08-09 | Option exercise · Stock Option (Right to Buy) 10b5-1 | −47,739 | 0 | D | ||
| Open-market sales · 47,739 sh · avg $84.26 · $4,022,488 | |||||||
Loading xslF345X05/ownership.xml…